Latest blog articles

Patent aggregation is one of the critical paths to raise revenue and earn a return on investment in the ICT sector. It comprises all activities whereby firms build sets of related patents, so-called patent portfolios, and subsequently use these beyond manufacturing. Different kinds of entities...

Constructing a functioning single market for business and trade among the Member States of the European Union (EU) has been the cornerstone of the EU project, and remains one of the strongest drivers for EU-level legislative reform. Over the years, the EU has prioritized the harmonization of...

The implementation of the Unitary Patent Package will represent the result of the evolution towards the unification of the European patent system.

Could you estimate how much time of your day you spend on social media? The answer would most likely be something along the lines of ‘a lot’ or ‘I’m always connected, so I get notifications all the time anyways’ but an actual estimate, that’s a very tough guess to take. However, for most people, it...

One view on social media communication is that platforms should remove content deemed to be inappropriate or disturbing and suspend users who have repeatedly violated the Community Guidelines and should do so in a consistent and coherent manner. A contrasting view is that users can share what they...

The disturbances social media has been causing to its users’ mental health cannot be ignored. It is of extreme importance that the private and public spheres work together to protect consumers from the unfeasible search for perfection.

Over the few past years, there has been a professionalization of social media content creators. These creators now have the power to sway their followers, start trends, or serve as role models for their audiences. These individuals, that have such online persuasive power, are called “influencers”...

The ongoing COVID-19 pandemic is arguably one of the biggest crises of modern times. The conflict between the search for a vaccine, and the artificial scarcity created by patent law, has created a catch-22 situation. How will patent law apply to a vaccine under these circumstances?

Several pharmaceutical companies all around the world, including in the European Union (EU), have been racing to find a treatment for the virus. Since these may be subject to patent rights, government intervention may be needed.

Electronics companies increasingly engage in patent aggregation, that is to accrue patents without using them for manufacturing purposes. So far, it is unclear whether such behaviour has negative effects on innovation. If it did, could EU competition law remedy it?